Blue Gold Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on September 3, 2025, reports material definitive agreements entered into by Blue Gold Limited (the "Company") on August 29, 2025. The filing details two primary financing arrangements: a secured convertible note offering and an equity line of credit (ELOC).
Key Financial Metrics and Capital Structure
- Convertible Notes: The Company agreed to sell up to $5,000,000 in aggregate purchase price for Senior Convertible Notes with an original principal amount of up to $5,434,783 (reflecting an 8% original issue discount).
- Initial Closing: On September 3, 2025, the Company received $3,500,000 in proceeds, issuing a Note with a principal of $3,804,348 and warrants to purchase 150,709 shares.
- Additional Tranche: A second tranche of $1,500,000 in proceeds (issuing a Note with a principal of $1,630,435 and warrants for 64,590 shares) is subject to customary conditions.
- Interest Rates: Notes bear interest at 7% per annum, increasing to 12% per annum upon an event of default.
- Equity Line of Credit (ELOC): The Company secured a commitment from an investor to purchase up to $75,000,000 in newly issued Ordinary Shares.
- Commitment Shares: The Company issued 69,419 Ordinary Shares to the investor as consideration for entering the ELOC agreement.
- Warrants: Warrants issued alongside the notes allow the purchase of up to 215,299 shares at an exercise price of $16.88 per share, exercisable from September 3, 2025, through September 3, 2030.
Material Changes and Agreements
The filing discloses significant changes to the Company's capital structure through the execution of the Securities Purchase Agreement and the ELOC Ordinary Share Purchase Agreement. The Company is now obligated to file registration statements with the SEC within 30 days to register the resale of the Note Shares, Warrant Shares, and ELOC shares, with effectiveness required within 60 days (or 15 days if not reviewed).
Guidance, Risks, and Covenants
- Conversion and Exercise Limits: The Buyer and Investor cannot convert notes or exercise warrants if it would result in beneficial ownership exceeding 4.99% (or 9.99% at their option) of outstanding shares.
- Negative Covenants: The Notes include restrictions on incurring additional indebtedness, creating liens, paying cash dividends, transferring assets, or changing the nature of the business.
- Indemnification: The Company must indemnify the Buyer for losses arising from misrepresentations, breaches of covenants, or third-party claims related to the transaction.
- Registration Risk: The Company cannot draw on the ELOC or sell shares until the relevant registration statement is declared effective by the SEC.
- Termination: The ELOC agreement terminates automatically on October 1, 2027, or upon bankruptcy proceedings, delisting, or assignment for the benefit of creditors.
Investor Verification Checklist
- Verify the effective date of the registration statements required for the resale of Note Shares, Warrant Shares, and ELOC shares.
- Confirm the current outstanding share count to assess the dilution impact of the 4.99% beneficial ownership limits.
- Review the Company's current liquidity position to ensure it can meet the 7% interest obligations on the $3.8 million initial note principal.
- Monitor the status of the second tranche closing conditions for the $1.5 million note issuance.
- Check for any existing indebtedness or liens that may conflict with the negative covenants in the new Note agreement.